Level of vision, not gain in letters seen, marks success of AMD treatment

The number of patients with a particular level of vision may be a better mark of the success of treatment for neovascular age-related macular degeneration than the gain or loss of letters able to be seen in logMAR chart testing, suggest researchers.

Full Story →